The Global Systemic Amyloidosis Therapeutic Market is estimated to be valued at USD 6.69 Bn in 2025 and is expected to reach USD 11.54 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2032. https://timessquarereporter.com/news/systemic-amyloidosis-therapeutic-market-anticipated-to-witness-growth-owing-to-innovative-treatments